Patent 9265690 was granted and assigned to Johnson & Johnson on February, 2016 by the United States Patent and Trademark Office.
A therapeutic apparatus includes an electrical stimulation delivery device, and at least one secondary modality delivery device, wherein the secondary modality delivery device is in an active state during at least a portion of a refractory period of the electrical stimulation delivery device.